Influence of Oxidative Stress and Inflammation on rHuEPO Requirements of Hemodialysis Patients With CRP Values "in Normal Range"

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3035-3040

  Tutal, E ^a   Sezer, S ^a   Bilgic, A ^a   Aldemir, D ^a   Turkoglu, S ^a   Demirel, O ^a   Ozdemir, N ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ERYTHROPOIETIN; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RECOMBINANT PROTEINS; REFERENCE VALUES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE;

EID: 37049002414     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.090     Document Type: Article

References (23)

1. Locatelli F., Canaud B., Eckardtet K.U., et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18 (2003) 1272
2. Stenvinkel P., and Barany P. Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17 suppl 5 (2002) 32
3. Depner T.A. Prescribing Hemodialysis: A Guide to Urea Modeling (1991), Kluwer, Boston MA 65
4. National Kidney Foundation. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 30 suppl 3 (1997) S192
5. Working Party for European Best Practice Guidelines for the Management of Anemia in Patients With Chronic Renal Failure: European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 14 suppl 5 (1999) ]?dS1/sb:first-page
6. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158
7. Yagi K. Assay for blood plasma or serum. Methods Enzymol 105 (1984) 328
8. Slater T.F. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 105 (1984) 283
9. Stenvinkel P., Heimbũrger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 (1999) 1899
10. Kalantar-Zadeh K., Stenvinkel P., Pillon L., et al. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther 10 (2003) 155
11. Phanish M.K., Marcora S.M., and Lemmey A.B. Malnutrition, chronic inflammation and atherosclerosis in dialysis patients. Nephrol Dial Transplant 18 (2003) 446
12. Yeun J.Y., Levine R.A., Mantadilok V., et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469
13. Kimmel P.L., Phillips T.M., Simmens S.J., et al. Immunologic function and survival in hemodialysis patients. Kidney Int 54 (1998) 236
14. Ducloux D., Bresson-Vautrin C., Kribs M., et al. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 62 (2002) 1417
15. Pecoits-Filho R., Barany P., Lindholm B., et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17 (2002) 1684
16. Wang A.Y., Woo J., Lam C.W., et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?. J Am Soc Nephrol 14 (2003) 1871
17. Opatma S., Klaboch J., Opatmy K., et al. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 25 (2005) 470
18. Conti G., Amore A., Chiesa M., et al. Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol 18 (2005) 282
19. Maroti Z., Nemeth I., Turi S., et al. Heme oxygenase 1 expression in young uremic patients on hemodialysis. Pediatr Nephrol 19 (2004) 426
20. Sommerburg O., Grune T., Harnpl H., et al. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysis patients?. Nephrol Dial Transplant 13 (1998) 2583
21. Calo L.A., Stanic L., Davis P.A., et al. Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients. Int J Clin Pharmacol Ther 41 (2003) 187
22. Maines M.D. Heme oxygenase function, multiplicity, regulatory mechanisms, and clinical applications. Faseb J 2 (1998) 2557
23. Tyrell R., and Basu-Modak S. Transient enchantment of heme oxygenase 1 mRNA accumulation: a marker of oxidative stress to eukaryotic cells. Methods Enzymol 234 (1994) 224